Net Loss of Jubilant Life Sciences reported to Rs 28.18 crore in the quarter ended March 2013 as against net loss of Rs 2.78 crore during the previous quarter ended March 2012. Sales rose 21.21% to Rs 840.66 crore in the quarter ended March 2013 as against Rs 693.56 crore during the previous quarter ended March 2012.
For the Audited full year,net loss reported to Rs 43.32 crore in the year ended March 2013 as against net loss of Rs 80.91 crore during the previous year ended March 2012. Sales rose 19.38% to Rs 3124.85 crore in the year ended March 2013 as against Rs 2617.64 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales840.66693.56 21 3124.852617.64 19 OPM %9.689.50 2 14.5315.72 -8 PBDT40.4422.78 78 291.88266.14 10 PBT-0.95-20.05 95 139.71134.14 4 NP-28.18-2.78 -914 -43.32-80.91 46
Powered by Capital Market - Live News
